SrasV1, PascalFrancis, Curation, bibRecord, 000987

Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses

Identifieur interne : 000987 ( PascalFrancis/Curation ); précédent : 000986; suivant : 000988

Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses

Auteurs : Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Alimuddin Zumla [Royaume-Uni, Arabie saoudite] ; Philippe Gautret [France] ; Gregory C. Gray [États-Unis] ; David S. Hui [Hong Kong] ; Abdullah A. Al-Rabeeah [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite]

Source :

Lancet. Infectious diseases : (print) [ 1473-3099 ] ; 2014.

RBID : Pascal:14-0256786

Descripteurs français

Pascal (Inist)
- Maladie émergente, Infection appareil respiratoire, Virose, Surveillance, Voie respiratoire, Coronavirus, Influenzavirus, Syndrome respiratoire du Moyen-Orient.

English descriptors

KwdEn :
- Coronavirus, Emerging disease, Influenzavirus, Middle East respiratory syndrome, Respiratory system infection, Respiratory tract, Surveillance, Viral disease.

Abstract

Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, causing more than 8000 cases and 800 deaths in more than 30 countries with a substantial economic impact. Since then, we have witnessed the emergence of several other viral respiratory pathogens including influenza viruses (avian influenza H5N1, H7N9, and H10N8; variant influenza A H3N2 virus), human adenovirus-14, and Middle East respiratory syndrome coronavirus (MERS-CoV). In response, various surveillance systems have been developed to monitor the emergence of respiratory-tract infections. These include systems based on identification of syndromes, web-based systems, systems that gather health data from health facilities (such as emergency departments and family doctors), and systems that rely on self-reporting by patients. More effective national, regional, and international surveillance systems are required to enable rapid identification of emerging respiratory epidemics, diseases with epidemic potential, their specific microbial cause, origin, mode of acquisition, and transmission dynamics.

A01	`01`	`1`		`@0 1473-3099`
A03		`1`		`@0 Lancet. Infect. dis. : (print)`
A05				`@2 14`
A06				`@2 10`
A08	`01`	`1`	`ENG`	`@1 Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses`
A11	`01`	`1`		`@1 AL-TAWFIQ (Jaffar A.)`
A11	`02`	`1`		`@1 ZUMLA (Alimuddin)`
A11	`03`	`1`		`@1 GAUTRET (Philippe)`
A11	`04`	`1`		`@1 GRAY (Gregory C.)`
A11	`05`	`1`		`@1 HUI (David S.)`
A11	`06`	`1`		`@1 AL-RABEEAH (Abdullah A.)`
A11	`07`	`1`		`@1 MEMISH (Ziad A.)`
A14	`01`			`@1 Johns Hopkins Aramco Healthcare @2 Dhahran @3 SAU @Z 1 aut.`
A14	`02`			`@1 Indiana University School of Medicine @2 Indianapolis, Indiana @3 USA @Z 1 aut.`
A14	`03`			`@1 Division of Infection and Immunity, University College London @2 London @3 GBR @Z 2 aut.`
A14	`04`			`@1 NIHR Biomedical Research Centre, University College London Hospitals @2 London @3 GBR @Z 2 aut.`
A14	`05`			`@1 Assistance Publique Hôpitaux de Marseille, CHU Nord, Pôle Infectieux, Institut Hospitalo-Universitaire Méditerranée Infection & Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE) @2 Marseille @3 FRA @Z 3 aut.`
A14	`06`			`@1 Global Center for Mass Gatherings Medicine, Ministry of Health @2 Riyadh @3 SAU @Z 2 aut. @Z 6 aut. @Z 7 aut.`
A14	`07`			`@1 Al-Faisal University @2 Riyadh @3 SAU @Z 7 aut.`
A14	`08`			`@1 Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida @3 USA @Z 4 aut.`
A14	`09`			`@1 Division of Respiratory Medicine and Stanley Ho Center for emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital @2 New Territories @3 HKG @Z 5 aut.`
A20				`@1 992-1000`
A21				`@1 2014`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 27478 @5 354000502640690250`
A44				`@0 0000 @1 © 2014 INIST-CNRS. All rights reserved.`
A45				`@0 124 ref.`
A47	`01`	`1`		`@0 14-0256786`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Lancet. Infectious diseases : (print)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, causing more than 8000 cases and 800 deaths in more than 30 countries with a substantial economic impact. Since then, we have witnessed the emergence of several other viral respiratory pathogens including influenza viruses (avian influenza H5N1, H7N9, and H10N8; variant influenza A H3N2 virus), human adenovirus-14, and Middle East respiratory syndrome coronavirus (MERS-CoV). In response, various surveillance systems have been developed to monitor the emergence of respiratory-tract infections. These include systems based on identification of syndromes, web-based systems, systems that gather health data from health facilities (such as emergency departments and family doctors), and systems that rely on self-reporting by patients. More effective national, regional, and international surveillance systems are required to enable rapid identification of emerging respiratory epidemics, diseases with epidemic potential, their specific microbial cause, origin, mode of acquisition, and transmission dynamics.
C02	`01`	`X`		`@0 002B05C`
C02	`02`	`X`		`@0 002B05C02C`
C03	`01`	`X`	`FRE`	`@0 Maladie émergente @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Emerging disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Enfermedad emergente @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Infection appareil respiratoire @2 NM @5 02`
C03	`02`	`X`	`ENG`	`@0 Respiratory system infection @2 NM @5 02`
C03	`02`	`X`	`SPA`	`@0 Infección del aparato respiratorio @2 NM @5 02`
C03	`03`	`X`	`FRE`	`@0 Virose @5 03`
C03	`03`	`X`	`ENG`	`@0 Viral disease @5 03`
C03	`03`	`X`	`SPA`	`@0 Virosis @5 03`
C03	`04`	`X`	`FRE`	`@0 Surveillance @5 07`
C03	`04`	`X`	`ENG`	`@0 Surveillance @5 07`
C03	`04`	`X`	`SPA`	`@0 Vigilancia @5 07`
C03	`05`	`X`	`FRE`	`@0 Voie respiratoire @5 08`
C03	`05`	`X`	`ENG`	`@0 Respiratory tract @5 08`
C03	`05`	`X`	`SPA`	`@0 Vía respiratoria @5 08`
C03	`06`	`X`	`FRE`	`@0 Coronavirus @2 NW @5 10`
C03	`06`	`X`	`ENG`	`@0 Coronavirus @2 NW @5 10`
C03	`06`	`X`	`SPA`	`@0 Coronavirus @2 NW @5 10`
C03	`07`	`X`	`FRE`	`@0 Influenzavirus @2 NW @5 11`
C03	`07`	`X`	`ENG`	`@0 Influenzavirus @2 NW @5 11`
C03	`07`	`X`	`SPA`	`@0 Influenzavirus @2 NW @5 11`
C03	`08`	`X`	`FRE`	`@0 Syndrome respiratoire du Moyen-Orient @4 CD @5 96`
C03	`08`	`X`	`ENG`	`@0 Middle East respiratory syndrome @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Infection`
C07	`01`	`X`	`ENG`	`@0 Infection`
C07	`01`	`X`	`SPA`	`@0 Infección`
C07	`02`	`X`	`FRE`	`@0 Coronaviridae @2 NW`
C07	`02`	`X`	`ENG`	`@0 Coronaviridae @2 NW`
C07	`02`	`X`	`SPA`	`@0 Coronaviridae @2 NW`
C07	`03`	`X`	`FRE`	`@0 Nidovirales @2 NW`
C07	`03`	`X`	`ENG`	`@0 Nidovirales @2 NW`
C07	`03`	`X`	`SPA`	`@0 Nidovirales @2 NW`
C07	`04`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`04`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`04`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`05`	`X`	`FRE`	`@0 Orthomyxoviridae @2 NW`
C07	`05`	`X`	`ENG`	`@0 Orthomyxoviridae @2 NW`
C07	`05`	`X`	`SPA`	`@0 Orthomyxoviridae @2 NW`
C07	`06`	`X`	`FRE`	`@0 Pathologie de l'appareil respiratoire @5 37`
C07	`06`	`X`	`ENG`	`@0 Respiratory disease @5 37`
C07	`06`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 37`
N21				`@1 315`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000000

Links to Exploration step

Pascal:14-0256786

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses</title>
<author><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A." last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Johns Hopkins Aramco Healthcare</s1>
<s2>Dhahran</s2>
<s3>SAU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Zumla, Alimuddin" sort="Zumla, Alimuddin" uniqKey="Zumla A" first="Alimuddin" last="Zumla">Alimuddin Zumla</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Infection and Immunity, University College London</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>NIHR Biomedical Research Centre, University College London Hospitals</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
</author>
<author><name sortKey="Gautret, Philippe" sort="Gautret, Philippe" uniqKey="Gautret P" first="Philippe" last="Gautret">Philippe Gautret</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Assistance Publique Hôpitaux de Marseille, CHU Nord, Pôle Infectieux, Institut Hospitalo-Universitaire Méditerranée Infection & Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE)</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Gray, Gregory C" sort="Gray, Gregory C" uniqKey="Gray G" first="Gregory C." last="Gray">Gregory C. Gray</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Hui, David S" sort="Hui, David S" uniqKey="Hui D" first="David S." last="Hui">David S. Hui</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Division of Respiratory Medicine and Stanley Ho Center for emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital</s1>
<s2>New Territories</s2>
<s3>HKG</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
</affiliation>
</author>
<author><name sortKey="Al Rabeeah, Abdullah A" sort="Al Rabeeah, Abdullah A" uniqKey="Al Rabeeah A" first="Abdullah A." last="Al-Rabeeah">Abdullah A. Al-Rabeeah</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
</author>
<author><name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A." last="Memish">Ziad A. Memish</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Al-Faisal University</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0256786</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0256786 INIST</idno>
<idno type="RBID">Pascal:14-0256786</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000000</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000987</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses</title>
<author><name sortKey="Al Tawfiq, Jaffar A" sort="Al Tawfiq, Jaffar A" uniqKey="Al Tawfiq J" first="Jaffar A." last="Al-Tawfiq">Jaffar A. Al-Tawfiq</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Johns Hopkins Aramco Healthcare</s1>
<s2>Dhahran</s2>
<s3>SAU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Zumla, Alimuddin" sort="Zumla, Alimuddin" uniqKey="Zumla A" first="Alimuddin" last="Zumla">Alimuddin Zumla</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Infection and Immunity, University College London</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>NIHR Biomedical Research Centre, University College London Hospitals</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
</author>
<author><name sortKey="Gautret, Philippe" sort="Gautret, Philippe" uniqKey="Gautret P" first="Philippe" last="Gautret">Philippe Gautret</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Assistance Publique Hôpitaux de Marseille, CHU Nord, Pôle Infectieux, Institut Hospitalo-Universitaire Méditerranée Infection & Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE)</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Gray, Gregory C" sort="Gray, Gregory C" uniqKey="Gray G" first="Gregory C." last="Gray">Gregory C. Gray</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Hui, David S" sort="Hui, David S" uniqKey="Hui D" first="David S." last="Hui">David S. Hui</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Division of Respiratory Medicine and Stanley Ho Center for emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital</s1>
<s2>New Territories</s2>
<s3>HKG</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Hong Kong</country>
</affiliation>
</author>
<author><name sortKey="Al Rabeeah, Abdullah A" sort="Al Rabeeah, Abdullah A" uniqKey="Al Rabeeah A" first="Abdullah A." last="Al-Rabeeah">Abdullah A. Al-Rabeeah</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
</author>
<author><name sortKey="Memish, Ziad A" sort="Memish, Ziad A" uniqKey="Memish Z" first="Ziad A." last="Memish">Ziad A. Memish</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Al-Faisal University</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Arabie saoudite</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Lancet. Infectious diseases : (print)</title>
<title level="j" type="abbreviated">Lancet. Infect.  dis. : (print)</title>
<idno type="ISSN">1473-3099</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Lancet. Infectious diseases : (print)</title>
<title level="j" type="abbreviated">Lancet. Infect.  dis. : (print)</title>
<idno type="ISSN">1473-3099</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronavirus</term>
<term>Emerging disease</term>
<term>Influenzavirus</term>
<term>Middle East respiratory syndrome</term>
<term>Respiratory system infection</term>
<term>Respiratory tract</term>
<term>Surveillance</term>
<term>Viral disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie émergente</term>
<term>Infection appareil respiratoire</term>
<term>Virose</term>
<term>Surveillance</term>
<term>Voie respiratoire</term>
<term>Coronavirus</term>
<term>Influenzavirus</term>
<term>Syndrome respiratoire du Moyen-Orient</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, causing more than 8000 cases and 800 deaths in more than 30 countries with a substantial economic impact. Since then, we have witnessed the emergence of several other viral respiratory pathogens including influenza viruses (avian influenza H5N1, H7N9, and H10N8; variant influenza A H3N2 virus), human adenovirus-14, and Middle East respiratory syndrome coronavirus (MERS-CoV). In response, various surveillance systems have been developed to monitor the emergence of respiratory-tract infections. These include systems based on identification of syndromes, web-based systems, systems that gather health data from health facilities (such as emergency departments and family doctors), and systems that rely on self-reporting by patients. More effective national, regional, and international surveillance systems are required to enable rapid identification of emerging respiratory epidemics, diseases with epidemic potential, their specific microbial cause, origin, mode of acquisition, and transmission dynamics.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1473-3099</s0>
</fA01>
<fA03 i2="1"><s0>Lancet. Infect.  dis. : (print)</s0>
</fA03>
<fA05><s2>14</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>AL-TAWFIQ (Jaffar A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>ZUMLA (Alimuddin)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GAUTRET (Philippe)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GRAY (Gregory C.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>HUI (David S.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>AL-RABEEAH (Abdullah A.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>MEMISH (Ziad A.)</s1>
</fA11>
<fA14 i1="01"><s1>Johns Hopkins Aramco Healthcare</s1>
<s2>Dhahran</s2>
<s3>SAU</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Indiana University School of Medicine</s1>
<s2>Indianapolis, Indiana</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Division of Infection and Immunity, University College London</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>NIHR Biomedical Research Centre, University College London Hospitals</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Assistance Publique Hôpitaux de Marseille, CHU Nord, Pôle Infectieux, Institut Hospitalo-Universitaire Méditerranée Infection & Aix Marseille Université, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE)</s1>
<s2>Marseille</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Global Center for Mass Gatherings Medicine, Ministry of Health</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Al-Faisal University</s1>
<s2>Riyadh</s2>
<s3>SAU</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Division of Respiratory Medicine and Stanley Ho Center for emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital</s1>
<s2>New Territories</s2>
<s3>HKG</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>992-1000</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>27478</s2>
<s5>354000502640690250</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>124 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0256786</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Lancet. Infectious diseases : (print)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, causing more than 8000 cases and 800 deaths in more than 30 countries with a substantial economic impact. Since then, we have witnessed the emergence of several other viral respiratory pathogens including influenza viruses (avian influenza H5N1, H7N9, and H10N8; variant influenza A H3N2 virus), human adenovirus-14, and Middle East respiratory syndrome coronavirus (MERS-CoV). In response, various surveillance systems have been developed to monitor the emergence of respiratory-tract infections. These include systems based on identification of syndromes, web-based systems, systems that gather health data from health facilities (such as emergency departments and family doctors), and systems that rely on self-reporting by patients. More effective national, regional, and international surveillance systems are required to enable rapid identification of emerging respiratory epidemics, diseases with epidemic potential, their specific microbial cause, origin, mode of acquisition, and transmission dynamics.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05C</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05C02C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie émergente</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Emerging disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Enfermedad emergente</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Infection appareil respiratoire</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Respiratory system infection</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Infección del aparato respiratorio</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Virose</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Viral disease</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Virosis</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Surveillance</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Surveillance</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vigilancia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Voie respiratoire</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Respiratory tract</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Vía respiratoria</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Coronavirus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Syndrome respiratoire du Moyen-Orient</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Middle East respiratory syndrome</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fN21><s1>315</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000987 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000987 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:14-0256786
   |texte=   Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses

Emerging respiratory tract infections 1: Surveillance for emerging respiratory viruses

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri